Gene-Tailored therapy shows promise for advanced lung cancer patients
NCT ID NCT00883480
First seen Apr 29, 2026 · Last updated Jun 16, 2026 · Updated 7 times
Summary
This study tested a personalized approach for 153 adults with advanced lung adenocarcinoma. Treatment was chosen based on specific gene mutations (EGFR and BRCA1) in each patient's tumor. The goal was to see if this tailored strategy could improve tumor shrinkage and overall survival compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Carlos Haya
Málaga, Málaga, Spain
-
Ico-Hospital Universitarios Germans Trias I Pujol
Badalona, Barcelona, 08916, Spain
Conditions
Explore the condition pages connected to this study.